美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Rapport Therapeutics, Inc.

28.67

-1.8700-6.12%

盘后：28.670.00000.00%16:20 EDT

成交量：29.30万

成交额：843.91万

市值：13.66亿

市盈率：-10.01

高：30.49

开：30.17

低：28.00

收：30.54

52周最高：42.27

52周最低：7.73

股本：4,766.11万

流通股本：2,656.72万

量比：0.57

换手率：1.10%

股息：- -

股息率：- -

每股收益(TTM):-2.8633

每股收益(LYR):-2.8633

净资产收益率：-28.22%

总资产收益率：-18.90%

市净率：2.82

市盈率(LYR):-10.01

数据加载中...

总览公司新闻资讯公告

Rapport Therapeutics与Tenacia Biotechnology宣布达成大中华区RAP-219开发与商业化战略合作

BUZZ--美国股票走势-Hims & Hers、Live Nation、NovaBridge

BUZZ-Rapport Therapeutics公司获得癫痫药物的中国销售权，业绩上升

Rapport Therapeutics与天纳西亚生物科技就Rap-219在大中华区的开发与商业化达成战略合作

Tenacia获Rap-219在大中华区独家开发和商业化权益

Rapport Therapeutics公司Rap-219三期临床试验计划将于2026年第二季度启动中国设试验基地

Rapport Therapeutics公司获2000万美元预付款，里程碑款项最高可达3.08亿美元，并享分层版税

Rapport Therapeutics计划于2027年上半年启动RAP-219治疗PGTCs的三期临床试验

BUZZ--美国股票走势-星座能源、威廉姆斯-索诺玛

BUZZ--美国股票走势-Lowe's, TJX Companies, Target

BUZZ--美国股票走势-Lowe's, TJX Companies, Target

BUZZ-BTIG 转而看好生物技术行业，认为 2026 年将是 "辉煌的一年

美国研究综述-安进、Crowdstrike、美光科技

Rapport Therapeutics：Rap-219 第二阶段临床试验进展顺利，预计2027年上半年公布主要结果

生物科技股复苏：四大因素推动行业上涨

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/RAPP/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RAPP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAPP\",,,,,undefined,":{"symbol":"RAPP","market":"US","secType":"STK","nameCN":"Rapport Therapeutics, Inc.","latestPrice":28.67,"timestamp":1773345600000,"preClose":30.54,"halted":0,"volume":293025,"hourTrading":{"tag":"盘后","latestPrice":28.67,"preClose":28.67,"latestTime":"16:20 EDT","volume":5602,"amount":160608.06,"timestamp":1773346800217,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.06123117223313679,"floatShares":26567199,"shares":47661138,"eps":-2.863342,"marketStatus":"未开盘","change":-1.87,"latestTime":"03-12 16:00:00 EDT","open":30.17,"high":30.485,"low":28.0027,"amount":8439134.461124,"amplitude":0.08128,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.863342,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1773388800000},"marketStatusCode":0,"adr":0,"listingDate":1717732800000,"exchange":"NASDAQ","adjPreClose":30.54,"preHourTrading":{"tag":"盘前","latestPrice":30.09,"preClose":30.54,"latestTime":"08:06 EDT","volume":18,"amount":541.62,"timestamp":1773317218822,"change":-0.45,"changeRate":-0.014735,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":28.67,"preClose":28.67,"latestTime":"16:20 EDT","volume":5602,"amount":160608.06,"timestamp":1773346800217,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.565808,"impliedVol":1.0093,"impliedVolPercentile":0.7012},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAPP\",,,,,undefined,":{"symbol":"RAPP","floatShares":26567199,"roa":"-18.90%","roe":"-28.22%","lyrEps":-2.863342,"volumeRatio":0.565808,"shares":47661138,"dividePrice":0,"high":30.485,"amplitude":0.08128,"preClose":30.54,"low":28.0027,"week52Low":7.73,"pbRate":"2.82","week52High":42.2685,"institutionHeld":0,"latestPrice":28.67,"eps":-2.863342,"divideRate":0,"volume":293025,"delay":0,"ttmEps":-2.863342,"open":30.17,"prevYearClose":30.34,"prevWeekClose":30.24,"prevMonthClose":29.03,"prevQuarterClose":30.34,"fiveDayClose":29.65,"twentyDayClose":27.64,"sixtyDayClose":30.27},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RAPP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-10","symbol":"RAPP","fiscalQuarterEnding":"2025/12","expectedEps":-0.65,"name":null,"time":"盘前","type":"earning","dateTimestamp":1773115200000,"reportTimeType":"pre","actualEps":-0.72},{"market":"US","date":"2025-11-06","symbol":"RAPP","fiscalQuarterEnding":"2025/09","expectedEps":-0.77,"name":null,"time":"盘前","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.71},{"market":"US","date":"2025-08-07","symbol":"RAPP","fiscalQuarterEnding":"2025/06","expectedEps":-0.87,"name":null,"time":"盘前","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.75},{"market":"US","date":"2025-05-08","symbol":"RAPP","fiscalQuarterEnding":"2025/03","expectedEps":-0.77,"name":null,"time":"盘前","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2025-03-11","symbol":"RAPP","fiscalQuarterEnding":"2024/12","expectedEps":-0.62,"name":null,"time":"盘前","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"pre","actualEps":-0.57}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RAPP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RAPP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.7,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7,"analysts":10,"updateTime":1770609600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RAPP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RAPP","date":"2026-03-11","current":-10.012775,"percent":0.403628,"low":-19.654107,"twenty":-14.288031,"median":-11.717047,"eighty":-5.801985,"high":-3.640031,"avg":-10.533447,"sd":4.082964,"marketCap":1416313555},"quantilePoints":[{"date":"2024-06-07","current":-14.341434,"twenty":-13.293406,"median":-11.721364,"eighty":-11.721364,"marketCap":735830305},{"date":"2024-06-14","current":-17.322989,"twenty":-16.966549,"median":-15.024031,"eighty":-12.769392,"marketCap":888807905},{"date":"2024-06-21","current":-15.733266,"twenty":-17.881887,"median":-15.772475,"eighty":-14.348329,"marketCap":807242405},{"date":"2024-06-28","current":-16.581593,"twenty":-17.17471,"median":-16.18238,"eighty":-14.635158,"marketCap":850768389},{"date":"2024-07-05","current":-17.059223,"twenty":-17.829134,"median":-16.431888,"eighty":-15.672154,"marketCap":875274616},{"date":"2024-07-12","current":-18.299635,"twenty":-18.057796,"median":-16.595851,"eighty":-15.733266,"marketCap":938917651},{"date":"2024-07-19","current":-14.343149,"twenty":-18.092899,"median":-16.610109,"eighty":-15.733266,"marketCap":735918314},{"date":"2024-07-26","current":-16.431888,"twenty":-18.057796,"median":-16.50674,"eighty":-14.592658,"marketCap":843087333},{"date":"2024-08-02","current":-15.740395,"twenty":-18.021611,"median":-16.417631,"eighty":-14.614044,"marketCap":807608170},{"date":"2024-08-09","current":-11.062669,"twenty":-17.829134,"median":-16.189509,"eighty":-14.507112,"marketCap":697147270},{"date":"2024-08-16","current":-12.078391,"twenty":-17.822005,"median":-15.897228,"eighty":-14.341434,"marketCap":761156070},{"date":"2024-08-23","current":-12.943207,"twenty":-17.322989,"median":-15.776039,"eighty":-12.769083,"marketCap":815654991},{"date":"2024-08-30","current":-12.623979,"twenty":-17.301602,"median":-15.672154,"eighty":-12.252515,"marketCap":795537939},{"date":"2024-09-06","current":-11.799793,"twenty":-17.107699,"median":-14.956226,"eighty":-12.030797,"marketCap":743599370},{"date":"2024-09-13","current":-11.027844,"twenty":-17.007896,"median":-14.603351,"eighty":-11.813723,"marketCap":694952683},{"date":"2024-09-20","current":-12.322165,"twenty":-16.6871,"median":-14.421566,"eighty":-11.752199,"marketCap":776518182},{"date":"2024-09-27","current":-12.380206,"twenty":-16.587296,"median":-14.342291,"eighty":-11.752199,"marketCap":780175827},{"date":"2024-10-04","current":-12.072587,"twenty":-16.581593,"median":-13.041877,"eighty":-11.742318,"marketCap":760790305},{"date":"2024-10-11","current":-12.798103,"twenty":-16.461829,"median":-12.783593,"eighty":-11.721364,"marketCap":806510876},{"date":"2024-10-18","current":-15.061713,"twenty":-16.461829,"median":-13.041877,"eighty":-11.742318,"marketCap":949159059},{"date":"2024-10-25","current":-14.057599,"twenty":-16.431888,"median":-14.106934,"eighty":-11.752199,"marketCap":885881788},{"date":"2024-11-01","current":-14.289764,"twenty":-16.420482,"median":-14.289764,"eighty":-11.78122,"marketCap":900512371},{"date":"2024-11-08","current":-13.587752,"twenty":-16.360601,"median":-14.196898,"eighty":-11.792828,"marketCap":976225637},{"date":"2024-11-15","current":-10.665545,"twenty":-16.293733,"median":-13.709352,"eighty":-11.752199,"marketCap":766276774},{"date":"2024-11-22","current":-11.755009,"twenty":-16.213426,"median":-13.641207,"eighty":-11.719637,"marketCap":844550392},{"date":"2024-11-29","current":-11.627735,"twenty":-16.188083,"median":-13.405914,"eighty":-11.573511,"marketCap":835406277},{"date":"2024-12-06","current":-10.416089,"twenty":-16.139607,"median":-12.943207,"eighty":-11.450385,"marketCap":748354310},{"date":"2024-12-13","current":-9.555718,"twenty":-15.982774,"median":-12.73716,"eighty":-11.371152,"marketCap":686540097},{"date":"2024-12-20","current":-9.199351,"twenty":-15.858733,"median":-12.415031,"eighty":-11.254059,"marketCap":660936577},{"date":"2024-12-27","current":-9.688083,"twenty":-15.824515,"median":-12.350651,"eighty":-11.045256,"marketCap":696049976},{"date":"2025-01-03","current":-9.917175,"twenty":-15.797425,"median":-12.316361,"eighty":-10.975704,"marketCap":712509382},{"date":"2025-01-10","current":-7.539701,"twenty":-15.740395,"median":-12.304752,"eighty":-10.859002,"marketCap":541697328},{"date":"2025-01-17","current":-6.460419,"twenty":-15.733266,"median":-12.215086,"eighty":-10.644772,"marketCap":464155239},{"date":"2025-01-24","current":-7.076424,"twenty":-15.684376,"median":-12.087097,"eighty":-10.43238,"marketCap":508412752},{"date":"2025-01-31","current":-8.354253,"twenty":-15.597056,"median":-11.915876,"eighty":-10.137105,"marketCap":600219659},{"date":"2025-02-07","current":-8.211706,"twenty":-15.257893,"median":-11.843324,"eighty":-9.686047,"marketCap":589978251},{"date":"2025-02-14","current":-8.094614,"twenty":-15.103195,"median":-11.828814,"eighty":-9.441681,"marketCap":581565666},{"date":"2025-02-21","current":-6.455328,"twenty":-15.070846,"median":-11.799793,"eighty":-9.297098,"marketCap":463789474},{"date":"2025-02-28","current":-5.106225,"twenty":-15.037336,"median":-11.771597,"eighty":-9.077168,"marketCap":366861863},{"date":"2025-03-07","current":-4.373128,"twenty":-15.01412,"median":-11.747556,"eighty":-8.771711,"marketCap":314191765},{"date":"2025-03-14","current":-4.898381,"twenty":-14.977526,"median":-11.717047,"eighty":-8.416363,"marketCap":383577552},{"date":"2025-03-21","current":-4.530187,"twenty":-14.817535,"median":-11.627735,"eighty":-8.164869,"marketCap":354745367},{"date":"2025-03-28","current":-4.68399,"twenty":-14.676319,"median":-11.461087,"eighty":-7.790176,"marketCap":366789191},{"date":"2025-04-04","current":-4.189957,"twenty":-14.640334,"median":-11.410917,"eighty":-7.133443,"marketCap":328102968},{"date":"2025-04-11","current":-4.315796,"twenty":-14.632186,"median":-11.370643,"eighty":-6.989878,"marketCap":337957006},{"date":"2025-04-17","current":-4.730597,"twenty":-14.622599,"median":-11.327444,"eighty":-6.74653,"marketCap":370438835},{"date":"2025-04-25","current":-4.949801,"twenty":-14.60549,"median":-11.189913,"eighty":-6.457364,"marketCap":387604034},{"date":"2025-05-02","current":-5.280719,"twenty":-14.55844,"median":-11.048158,"eighty":-5.528775,"marketCap":413517298},{"date":"2025-05-09","current":-4.693792,"twenty":-14.472894,"median":-10.976093,"eighty":-5.332796,"marketCap":374099938},{"date":"2025-05-16","current":-4.560992,"twenty":-14.4176,"median":-10.940782,"eighty":-5.2164,"marketCap":363515647},{"date":"2025-05-23","current":-5.092192,"twenty":-14.397354,"median":-10.8247,"eighty":-5.097805,"marketCap":405852811},{"date":"2025-05-30","current":-3.896992,"twenty":-14.370288,"median":-10.665545,"eighty":-4.981023,"marketCap":310594193},{"date":"2025-06-06","current":-5.646289,"twenty":-14.346875,"median":-10.527934,"eighty":-4.950803,"marketCap":450014853},{"date":"2025-06-13","current":-5.101351,"twenty":-14.342806,"median":-10.416089,"eighty":-4.981023,"marketCap":406582762},{"date":"2025-06-20","current":-5.050978,"twenty":-14.341434,"median":-10.309179,"eighty":-5.014344,"marketCap":402568031},{"date":"2025-06-27","current":-5.408165,"twenty":-14.289764,"median":-9.866266,"eighty":-5.000606,"marketCap":431036124},{"date":"2025-07-03","current":-5.513507,"twenty":-14.247974,"median":-9.698265,"eighty":-5.011596,"marketCap":439432031},{"date":"2025-07-11","current":-7.043002,"twenty":-14.172521,"median":-9.586263,"eighty":-5.043651,"marketCap":561334272},{"date":"2025-07-18","current":-6.795718,"twenty":-14.077333,"median":-9.430989,"eighty":-5.078884,"marketCap":541625526},{"date":"2025-07-25","current":-7.610838,"twenty":-13.779001,"median":-9.362262,"eighty":-5.090926,"marketCap":606591391},{"date":"2025-08-01","current":-6.57591,"twenty":-13.6976,"median":-9.168805,"eighty":-5.092192,"marketCap":524106641},{"date":"2025-08-08","current":-6.368661,"twenty":-13.694662,"median":-9.054259,"eighty":-5.099519,"marketCap":562429202},{"date":"2025-08-15","current":-6.17446,"twenty":-13.609134,"median":-8.982986,"eighty":-5.10525,"marketCap":545278924},{"date":"2025-08-22","current":-6.170327,"twenty":-13.473486,"median":-8.4968,"eighty":-5.115317,"marketCap":544913945},{"date":"2025-08-29","current":-6.943168,"twenty":-13.38251,"median":-8.407708,"eighty":-5.122916,"marketCap":613165056},{"date":"2025-09-05","current":-6.343907,"twenty":-13.171889,"median":-8.282979,"eighty":-5.126995,"marketCap":560243072},{"date":"2025-09-12","current":-9.588184,"twenty":-13.020376,"median":-8.364435,"eighty":-5.143059,"marketCap":846751744},{"date":"2025-09-19","current":-14.281097,"twenty":-13.398113,"median":-8.486618,"eighty":-5.165131,"marketCap":1261192245},{"date":"2025-09-26","current":-13.038354,"twenty":-13.650327,"median":-8.934622,"eighty":-5.176938,"marketCap":1151443158},{"date":"2025-10-03","current":-14.902468,"twenty":-13.718742,"median":-9.051713,"eighty":-5.195691,"marketCap":1316066789},{"date":"2025-10-10","current":-13.962579,"twenty":-13.896787,"median":-9.158623,"eighty":-5.223161,"marketCap":1233063277},{"date":"2025-10-17","current":-12.986138,"twenty":-13.856058,"median":-9.228454,"eighty":-5.262092,"marketCap":1146831851},{"date":"2025-10-24","current":-13.675391,"twenty":-13.856058,"median":-9.397898,"eighty":-5.294604,"marketCap":1207701093},{"date":"2025-10-31","current":-14.035682,"twenty":-13.934383,"median":-9.502263,"eighty":-5.303959,"marketCap":1239519106},{"date":"2025-11-07","current":-11.969573,"twenty":-13.970933,"median":-9.588184,"eighty":-5.319746,"marketCap":1169427252},{"date":"2025-11-14","current":-12.034803,"twenty":-13.934383,"median":-9.698265,"eighty":-5.33408,"marketCap":1175800274},{"date":"2025-11-21","current":-13.098276,"twenty":-13.915585,"median":-9.917175,"eighty":-5.342242,"marketCap":1279701555},{"date":"2025-11-28","current":-14.493474,"twenty":-13.931568,"median":-10.309179,"eighty":-5.356195,"marketCap":1416012409},{"date":"2025-12-05","current":-14.000764,"twenty":-13.954437,"median":-10.426271,"eighty":-5.376155,"marketCap":1367874660},{"date":"2025-12-12","current":-14.039791,"twenty":-13.99491,"median":-10.604143,"eighty":-5.393122,"marketCap":1371687551},{"date":"2025-12-19","current":-14.459326,"twenty":-14.050476,"median":-10.719003,"eighty":-5.431972,"marketCap":1412676130},{"date":"2025-12-26","current":-15.088628,"twenty":-14.119227,"median":-10.841851,"eighty":-5.476848,"marketCap":1474158998},{"date":"2026-01-02","current":-14.800808,"twenty":-14.281097,"median":-10.940782,"eighty":-5.513507,"marketCap":1446038926},{"date":"2026-01-09","current":-13.81051,"twenty":-14.281097,"median":-10.976093,"eighty":-5.513507,"marketCap":1349286816},{"date":"2026-01-16","current":-13.103154,"twenty":-14.237527,"median":-11.048158,"eighty":-5.513507,"marketCap":1280178166},{"date":"2026-01-23","current":-13.620256,"twenty":-14.172521,"median":-11.156822,"eighty":-5.535473,"marketCap":1330698972},{"date":"2026-01-30","current":-13.049493,"twenty":-14.13499,"median":-11.312246,"eighty":-5.592253,"marketCap":1274935441},{"date":"2026-02-06","current":-12.464095,"twenty":-14.128014,"median":-11.370643,"eighty":-5.617345,"marketCap":1217742075},{"date":"2026-02-13","current":-13.644647,"twenty":-14.087483,"median":-11.410917,"eighty":-5.641114,"marketCap":1333082029},{"date":"2026-02-20","current":-14.630067,"twenty":-14.14031,"median":-11.45735,"eighty":-5.660027,"marketCap":1429357528},{"date":"2026-02-27","current":-14.391029,"twenty":-14.240388,"median":-11.53826,"eighty":-5.735139,"marketCap":1406003571},{"date":"2026-03-06","current":-14.464204,"twenty":-14.259247,"median":-11.689515,"eighty":-5.790087,"marketCap":1413152741},{"date":"2026-03-11","current":-12.704301,"twenty":-14.288031,"median":-11.717047,"eighty":-5.801985,"marketCap":1416313555}],"updateTime":1773358452603},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RAPP\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618530677","title":"Rapport Therapeutics与Tenacia Biotechnology宣布达成大中华区RAP-219开发与商业化战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2618530677","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618530677?lang=zh_cn&edition=fundamental","pubTime":"2026-03-10 04:34","pubTimestamp":1773088440,"startTime":"0","endTime":"0","summary":"2025年9月，Rapport公布了RAP-219在耐药性局灶性发作癫痫患者中开展的2a期试验结果。RAP-219总体耐受性良好。Tenacia将负责RAP-219在大中华区的开发与商业化，而Rapport保留全球其他所有地区的权益。关于Rapport Therapeutics Rapport Therapeutics是一家处于临床阶段的生物技术公司，致力于为患有神经系统疾病和精神疾病的患者发现并开发小分子精准药物。关于Tenacia Biotechnology Tenacia由Bain Capital于2022年创立，是一家处于商业化阶段的生物制药公司，致力于为患有未被充分满足治疗需求的神经系统疾病患者开发创新疗法。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/09/3252334/0/zh-hans/Rapport-Therapeutics%E4%B8%8ETenacia-Biotechnology%E5%AE%A3%E5%B8%83%E8%BE%BE%E6%88%90%E5%A4%A7%E4%B8%AD%E5%8D%8E%E5%8C%BARAP-219%E5%BC%80%E5%8F%91%E4%B8%8E%E5%95%86%E4%B8%9A%E5%8C%96%E6%88%98%E7%95%A5%E5%90%88%E4%BD%9C.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","RAPP","LENZ","BK4139"],"gpt_icon":0},{"id":"2618621524","title":"BUZZ--美国股票走势-Hims & Hers、Live Nation、NovaBridge","url":"https://stock-news.laohu8.com/highlight/detail?id=2618621524","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618621524?lang=zh_cn&edition=fundamental","pubTime":"2026-03-09 21:30","pubTimestamp":1773063020,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nL4S3ZX1CQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2Q91V27.USD","HIMZ","PFE","CAT","LU0162691827.USD","VRTL","FCEL","UAL","HIYY","HIMS","DTIL","AAL","LU2462611646.USD","HIMY","RLMD","VRT","HMYY","LU0433182093.SGD","RAPP","NEM","LU1894683264.USD","LYV","SATG","COP","AGH","AU","XOMX","AALG","ITT","DAL","NWMX","XOMZ","CDE","LUV","SATS","NEMG","HL","LU0170899867.USD","LITX","NBP","PLD","XENE","SLB","COHX","BARC.UK","XOMO"],"gpt_icon":1},{"id":"2618625612","title":"BUZZ-Rapport Therapeutics公司获得癫痫药物的中国销售权，业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2618625612","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618625612?lang=zh_cn&edition=fundamental","pubTime":"2026-03-09 20:09","pubTimestamp":1773058157,"startTime":"0","endTime":"0","summary":"BUZZ-Rapport Therapeutics公司获得癫痫药物的中国销售权，业绩上升3月9日 - ** 药物开发商Rapport Therapeutics RAPP.O股价盘前上涨6.45%至32.19美元** 公司称已授予Tenacia其实验性癫痫药物RAP-219的大中华区独家代理权** 该公司称，RAPP的RAP-219旨在治疗局灶性癫痫发作和双相躁狂症。** 该公司称，Tenacia公司将在中国进行试验并将该药物商业化；Rapport公司将获得2,000万美元的预付款，以及高达3.08亿美元的里程碑和特许权使用费。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nL4S3ZX161:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"gpt_icon":0},{"id":"1179109765","title":"Rapport Therapeutics与天纳西亚生物科技就Rap-219在大中华区的开发与商业化达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1179109765","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179109765?lang=zh_cn&edition=fundamental","pubTime":"2026-03-09 19:04","pubTimestamp":1773054297,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics, Inc. 与天纳西亚生物科技公司今日共同宣布，双方已达成一项战略性合作协议，将携手推进创新药物Rap-219在大中华区（包括中国大陆、香港、澳门及台湾）的开发与商业化进程。此次合作旨在整合双方在研发、临床及市场拓展方面的优势资源，加速该疗法惠及广大患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","BK4007"],"gpt_icon":0},{"id":"1167170585","title":"Tenacia获Rap-219在大中华区独家开发和商业化权益","url":"https://stock-news.laohu8.com/highlight/detail?id=1167170585","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167170585?lang=zh_cn&edition=fundamental","pubTime":"2026-03-09 19:03","pubTimestamp":1773054230,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics, Inc. 宣布，Tenacia公司已获得其候选药物Rap-219在大中华区（包括中国大陆、香港、澳门和台湾）的独家开发和商业化权利。此次授权合作将加速该疗法在亚太市场的布局，为当地患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"gpt_icon":0},{"id":"1157887434","title":"Rapport Therapeutics公司Rap-219三期临床试验计划将于2026年第二季度启动 中国设试验基地","url":"https://stock-news.laohu8.com/highlight/detail?id=1157887434","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157887434?lang=zh_cn&edition=fundamental","pubTime":"2026-03-09 19:03","pubTimestamp":1773054220,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics公司近日披露，其创新药物Rap-219的三期临床试验项目预计于2026年第二季度正式启动。值得关注的是，该全球临床试验网络将涵盖中国地区的多个研究中心，标志着中国在神经科学领域临床研究布局的重要性日益凸显。此次试验站点的拓展，不仅有助于加速患者招募进程，更将促进亚太地区前沿医疗资源的整合与共享。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","BK4007"],"gpt_icon":0},{"id":"1105416410","title":"Rapport Therapeutics公司获2000万美元预付款，里程碑款项最高可达3.08亿美元，并享分层版税","url":"https://stock-news.laohu8.com/highlight/detail?id=1105416410","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105416410?lang=zh_cn&edition=fundamental","pubTime":"2026-03-09 19:03","pubTimestamp":1773054204,"startTime":"0","endTime":"0","summary":"生物制药企业Rapport Therapeutics公司近日宣布达成一项重要合作协议。根据协议条款，该公司将获得2000万美元的预付款，并有资格获得最高可达3.08亿美元的里程碑款项。此外，协议还包含了基于产品销售业绩的分层版税安排。这一合作标志着Rapport Therapeutics在创新疗法开发领域取得了重大进展，为其未来的研发工作提供了坚实的资金支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"gpt_icon":0},{"id":"1131033553","title":"Rapport Therapeutics计划于2027年上半年启动RAP-219治疗PGTCs的三期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1131033553","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131033553?lang=zh_cn&edition=fundamental","pubTime":"2026-01-07 20:08","pubTimestamp":1767787738,"startTime":"0","endTime":"0","summary":"生物制药公司Rapport Therapeutics, Inc.近日披露重要研发进展，宣布将于2027年上半年正式启动其核心候选药物RAP-219针对原发性全身性强直阵挛发作的三期临床试验。这一关键性临床阶段的启动，标志着该药物在癫痫治疗领域的开发迈入决定性阶段。业界关注到，RAP-219作为一种创新疗法，其临床进展对满足PGTCs患者的未竟医疗需求具有重要意义。此次三期试验的启动计划，不仅体现了Rapport Therapeutics在神经科学领域的研发实力，也可能为癫痫治疗格局带来新的变革。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"gpt_icon":0},{"id":"2584923536","title":"BUZZ--美国股票走势-星座能源、威廉姆斯-索诺玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2584923536","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584923536?lang=zh_cn&edition=fundamental","pubTime":"2025-11-19 23:59","pubTimestamp":1763567988,"startTime":"0","endTime":"0","summary":"标普500指数.SPX上涨0.90%，报6,676.77点；纳斯达克综合指数.IXIC上涨1.48%，报22,763.88点。nL6N3WV0P7 ** Agios Pharmaceuticals Inc AGIO.O:BUZZ - 因镰状细胞药物未能达到疼痛危机目标而下挫。nL6N3WV0QE ** TJX Companies Inc TJX.N:BUZZ - TJ Maxx 母公司 TJX 上调年度预期后股价上涨   nL6N3WV0R7 ** Sociedad Quimica y Minera de Chile SA SQM.N:BUZZ - 因业绩和预测看涨而上扬，提振锂业同行   nL6N3W","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nL4S3WV1FP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DOW","GLAD","AGIO","DY","HL","DLB","U","GLBE","NUVL","ALZN","H","RDW","ONCY","LOW","FCX","SEMR","XOM","SCCO","MAR","AVDL","COP","CVX","VTVT","CDE","ON","NNOX","OWL","CURB","RAPP","SION","GEV","LYB","TGT","NNE","CEVA","WSM","CEG","PRAX","ZION","DASH","TJX"],"gpt_icon":1},{"id":"2584942096","title":"BUZZ--美国股票走势-Lowe's, TJX Companies, Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2584942096","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584942096?lang=zh_cn&edition=fundamental","pubTime":"2025-11-19 22:25","pubTimestamp":1763562342,"startTime":"0","endTime":"0","summary":".N** 杜比实验室公司DLB.N：BUZZ - 节假日期间的季度业绩预期不及预期，股价下跌。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nL4T3WV18U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DASH","NVDD","AU","2NVD.UK","RIO.UK","SEMR","TGT","SION","CARV","AVDL","RAPP","NVD2.UK","DLB","BHP.AU","RIO.AU","GLAD","SCCO","NVIW.SI","PPL","HL","CEVA","NVD","SNVD.UK","NVD3.UK","AGIO","TJX","DOW","FCX","ALZN","NVDS.UK","ON","GEV","PRAX","ALKS","CDE","CURB","VTVT","ZION","LYB","LOW"],"gpt_icon":1},{"id":"2584594209","title":"BUZZ--美国股票走势-Lowe's, TJX Companies, Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2584594209","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584594209?lang=zh_cn&edition=fundamental","pubTime":"2025-11-19 22:25","pubTimestamp":1763562342,"startTime":"0","endTime":"0","summary":".N** 杜比实验室公司DLB.N：BUZZ - 节假日期间的季度业绩预期不及预期，股价下跌。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nL4S3WV18U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DASH","NVDX","NVDD","AU","RIO.UK","SEMR","TGT","SION","CARV","AVDL","RAPP","NVD2.UK","DLB","BHP.AU","RIO.AU","GLAD","SCCO","PPL","HL","CEVA","NVD","NVD3.UK","AGIO","TJX","DOW","FCX","ALZN","ON","GEV","PRAX","ALKS","NVDS","NVDU","CDE","CURB","VTVT","ZION","LYB","LOW"],"gpt_icon":1},{"id":"2584100459","title":"BUZZ-BTIG 转而看好生物技术行业，认为 2026 年将是 \"辉煌的一年","url":"https://stock-news.laohu8.com/highlight/detail?id=2584100459","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584100459?lang=zh_cn&edition=fundamental","pubTime":"2025-11-19 19:02","pubTimestamp":1763550138,"startTime":"0","endTime":"0","summary":"BUZZ-BTIG 转而看好生物技术行业，认为 2026 年将是 \"辉煌的一年11月19日 - ** BTIG 表示，随着利率下调和并购活动的增加，2025 年中小市值生物技术股将迎来利好因素** 监管效率的提高可能是 2026 年生物技术行业的主要利好因素--BTIG** 我们认为 2026 年将是辉煌的一年。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nL4S3WV0U7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","PRAX","SION","LU0320765992.SGD","VTVT","RAPP","BK4007","BK4139","LU0889565916.HKD"],"gpt_icon":0},{"id":"2584918469","title":"美国研究综述-安进、Crowdstrike、美光科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2584918469","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584918469?lang=zh_cn&edition=fundamental","pubTime":"2025-11-19 15:17","pubTimestamp":1763536643,"startTime":"0","endTime":"0","summary":"美国研究综述-安进、Crowdstrike、美光科技路透11月19日 - 华尔街证券分析师周三调整了对安进公司、Crowdstrike 和美光科技等几家美国上市公司的评级和目标价。要闻 * 安进公司AMGN.O：汇丰银行将目标价从343美元上调至381美元 * Crowdstrike CRWD.O：杰富瑞将目标价从515美元上调至600美元 * 美光科技MU.O：TD Cowen将目标价从200美元上调至275美元 * Praxis Precision Medicines Inc PRAX.O：BTIG给予买入评级 * Universal Health Services Inc UHS.N：摩根大通将目标价从195美元上调至240美元以下是路透周三报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nL4S3WV0H4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306685.HKD","IPAR","PCVX","RAPP","LU1934455194.USD","HD","INCY","SG9999014674.SGD","WCC","MU","PRAX","ZYME","LU0128525929.USD","ZION","CRWD","NUVB","VTVT","LU0353189763.USD","ARWR","LU1116320737.USD","MBI","DKS","BRBR","LU0417516738.SGD","KNTK","SION","LU0287142896.SGD","OLMA","LGIH","FCX","LU1328615791.USD","LU0819121731.USD","AMGN","LU0029864427.USD","TERN","DASH","RARE","COTY","LU1941712348.USD","BK1609","ENR","89888","IE00BWXC8680.SGD","LU0823414478.USD","UHS","BK4514"],"gpt_icon":1},{"id":"1117807206","title":"Rapport Therapeutics：Rap-219 第二阶段临床试验进展顺利，预计2027年上半年公布主要结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1117807206","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117807206?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 20:22","pubTimestamp":1762431766,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics：Rap-219 第二阶段临床试验进展顺利，预计2027年上半年公布主要结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"gpt_icon":0},{"id":"2581214792","title":"生物科技股复苏：四大因素推动行业上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2581214792","media":"金十数据","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581214792?lang=zh_cn&edition=fundamental","pubTime":"2025-11-04 16:52","pubTimestamp":1762246369,"startTime":"0","endTime":"0","summary":"经过四年的低迷期，生物科技行业正在迎来复苏，多个因素推动其股价回升。这种单日上涨的幅度吸引了投资者的注意，进一步支持了生物科技股的上涨。这使得整个行业更容易继续上涨。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104173307a48768cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104173307a48768cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2552382058.USD","LU2360106947.USD","HHS","LU2552382215.SGD","BK4007","IE0002141913.USD","LU2602419157.SGD","ARGX","LU2211815571.USD","ALKS","LU1983299246.USD","RAPP","LU1718418525.SGD","BK4009","BMY","LU2129689605.HKD","MDGL","LU0122379950.USD","LU0203201768.USD","PRAX","BK4585","LU1551013342.USD","LU0321505868.SGD","LU0203202063.USD","LU0128525929.USD","LU0203347892.USD","BK4548","LU0234570918.USD","ALNY","MBX","LU2324357040.USD","BBIO","XBI","SG9999013999.USD","QURE","SG9999011175.SGD","ABBV","IE00BBT3K403.USD","MEDI","ASND","LU1934455194.USD","LU2237443382.USD","LU1623119135.USD","LU0985481810.HKD","LU0237698245.USD","AMGN","SG9999015986.USD","NBIX"],"gpt_icon":1}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}